Osteomalacia
📧 Sign up to get email alerts when something new happens for Osteomalacia.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-10EMA Authorised: Crysvita (burosumab) — Kyowa Kirin Holdings B.V.
EU authorization for Crysvita (burosumab) for familial hypophosphatemia, X-linked dominant hypophosphatemic rickets, and osteomalacia, grant…
-
EMA approval · 2026-04-08EMA Authorised: Crysvita (burosumab) — Kyowa Kirin Holdings B.V.
The EMA authorised Crysvita (burosumab) for X-linked hypophosphatemia and related familial hypophosphatemia and osteomalacia indications, wi…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Natural History Study of Bone and Mineral Disorders
A ClinicalTrials.gov listing indicates a natural history study of bone and mineral disorders is currently recruiting, focusing on tumor-indu…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients
Post-marketing surveillance study to observe the safety and effectiveness of CRYSVITA (burosumab) in South Korean patients with FGF23-relate…
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia [Phase 1, Phase 2]
This phase 1/2 trial evaluates gallium-68 DOTATATE PET imaging to localize phosphaturic mesenchymal tumors causing tumor-induced osteomalaci…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: A Study of KRN23 in Adult and Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia [Phase 3]
Phase 3 trial update for KRN23 in adults and children with X-linked hypophosphatemic rickets/osteomalacia (XLH) completed.
-
CLINICAL_TRIALS trial_result · 2018-09-25Clinical Trial Update: Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH) [Phase 3]
Open-label Phase 3 study evaluating KRN23 for osteomalacia in adults with X-linked hypophosphatemia completed; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets) [Phase 1]
A Phase 1 trial of cinacalcet for FGF23-mediated hypophosphatemia causing hypophosphatemic rickets has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Catheterization to Locate Mesenchymal Tumors in Patients With Tumor-Induced Osteomalacia or Oncogenic Osteomalacia
This record notes a completed clinical trial investigating catheter-based localization of mesenchymal tumors in patients with tumor-induced …
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia [Phase 1]
Phase 1 study of KRN23 in X-linked hypophosphatemia with osteomalacia has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-14Clinical Trial Update: Maternal and Infant Vitamin Status During the First Nine Months of Infant Life
This is a completed clinical trial update examining maternal and infant vitamin status during the first nine months of life.
-
CLINICAL_TRIALS trial_result · 2014-07-21Clinical Trial Update: Vitamin D Status in Males in Jerusalem Area and Its Correlation to Parathyroid Hormone (PTH) Level and Bone Mineral Density [Phase 4]
Phase 4 clinical trial in Jerusalem area evaluating vitamin D status in men and its relationship to parathyroid hormone levels and bone mine…
-
FDA approval · 2013-05-15FDA Approved: CALCITRIOL — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for CALCITRIOL (calcitriol) from Sun Pharmaceutical Industries, Inc., updating the product’s reg…
-
FDA approval · 2010-08-03FDA Approved: VITAMIN D — Original Application (Strides Pharma Science Limited)
FDA approves Strides Pharma Science Limited's generic vitamin D product ergocalciferol under an Original Application (ANDA 090455).
-
CLINICAL_TRIALS trial_result · 2010-04-13Clinical Trial Update: Serum FGF-23 and Vitamin D Deficiency
Completed clinical trial investigating the relationship between serum FGF-23 and vitamin D deficiency in osteomalacia.